Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Oct 2009 03:41 PM
RNS
Holding(s) in Company
12 Oct 2009 03:10 PM
RNS
Director/PDMR Shareholding
06 Oct 2009 07:30 AM
RNS
Final Results
01 Oct 2009 07:00 AM
RNS
Director/PDMR Shareholding
18 Sep 2009 09:08 AM
RNS
Notice of Preliminary Results
18 Aug 2009 03:29 PM
RNS
Additional Listing
30 Jul 2009 07:30 AM
RNS
Pre-Close Trading Update
13 Jul 2009 10:46 AM
RNS
Holding(s) in Company
13 Jul 2009 10:10 AM
RNS
Director/PDMR Shareholding
10 Jun 2009 09:50 AM
RNS
Holding(s) in Company
02 Jun 2009 07:08 AM
Epistem Presents Further Data Supporting Its Pl...
20 Apr 2009 10:08 AM
Epistem Present at AACR Meeting in Denver
14 Apr 2009 07:06 AM
Epistem to Present Erlotinib Biomarker Data at ...
30 Mar 2009 03:22 PM
RNS
Director Declaration
17 Mar 2009 05:08 PM
RNS
Additional Listing
11 Mar 2009 07:04 AM
RNS
Half Yearly Report
02 Mar 2009 07:00 AM
RNS
Re Agreement
02 Mar 2009 07:00 AM
PRN
Epistem Announces Research and Development Coll...
24 Feb 2009 11:22 AM
RNS
Notice of Results
05 Dec 2008 07:30 AM
RNS
Annual Report and Accounts
28 Nov 2008 07:30 AM
RNS
Change of Nomad and Adviser
10 Nov 2008 07:30 AM
RNS
Change of Nomad and Adviser
13 Oct 2008 08:54 AM
RNS
Issue of Equity & TVR
08 Oct 2008 03:19 PM
RNS
Change of Adviser Name
06 Oct 2008 07:00 AM
RNS
Preliminary Results - October
01 Sep 2008 07:30 AM
RNS
EPISTEM AND ROTTAPHARM ANNOUN
31 Jul 2008 11:06 AM
RNS
Trading Update
24 Jul 2008 08:54 AM
RNS
EPISTEM ANNOUNCE COLLABORATIO
23 Jun 2008 07:00 AM
RNS
MASCC Conference
07 Apr 2008 07:09 AM
Epistem to Announce Data on Its Stem Cell Cance...
07 Apr 2008 07:01 AM
RNS
Data to be Released at AACR
01 Apr 2008 10:31 AM
RNS
Epistem services for EBI
05 Mar 2008 04:31 PM
RNS
Senior Management Appointment
28 Feb 2008 07:30 AM
RNS
Interim Results
12 Feb 2008 11:57 AM
RNS
Notice of Results
05 Feb 2008 11:40 AM
PRN
Epistem plc and AstraZeneca Complete Plucked Ha...
30 Nov 2007 04:23 PM
RNS
Total Voting Rights
28 Nov 2007 02:17 PM
RNS
AGM Statement
20 Nov 2007 03:32 PM
RNS
Issue of Equity
02 Nov 2007 08:56 AM
RNS
Notifiable Interest
02 Nov 2007 08:41 AM
RNS
Notice of AGM
23 Oct 2007 10:15 AM
RNS
Director/PDMR Shareholding
10 Oct 2007 07:01 AM
RNS
Preliminary Results
20 Sep 2007 10:24 AM
PRN
EpiStem Successfully Complete First Year Of Muc...
20 Sep 2007 07:01 AM
RNS
Research Update
17 Aug 2007 09:57 AM
RNS
AIM Rule 26
31 Jul 2007 07:01 AM
RNS
Trading Update
28 Jun 2007 02:16 PM
RNS
Directors Shareholdings
22 May 2007 07:30 AM
RNS
Research Update
04 Apr 2007 08:00 AM
RNS
Admission to AIM

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings